The Cell Biology of Myelin Degeneration and Regeneration in the Peripheral Nervous System

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 9, 1996, Pages 943-953

  Goodrum, Jeffry F ^a   Bouldin, Thomas W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Lipoproteins; Macrophage; Myelin lipids; Peripheral nerve; Sehwann cell; Wallerian degeneration

Indexed keywords

ANIMAL; DEMYELINATING DISEASE; MYELIN SHEATH; NERVE DEGENERATION; NERVE REGENERATION; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; REVIEW;

ANIMALS; DEMYELINATING DISEASES; MYELIN SHEATH; NERVE DEGENERATION; NERVE REGENERATION; PERIPHERAL NERVOUS SYSTEM;

EID: 0030240107     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199609000-00001     Document Type: Article

References (47)

1. Bunge RP, Griffin JW. The cell of Schwann. In: Asbury AK, McKhann GM, McDonald WI, eds. Diseases of the nervous system, second ed. Philadelphia: W.B. Saunders Co, 1992;1:87-100
2. Perry VH, Brown MC. Role of macrophages in peripheral nerve degeneration and repair. BioEssays 1992;14:401-6
3. Griffin JW, Hoffman PN. Degeneration and regeneration in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA Poduslo JF, eds. Peripheral Neuropathy, third ed. Philadelphia: W.B. Saunders Co, 1993:361-76
4. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves. A review. J Neuropath Exp Neurol 1993;52:553-60
5. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1994;18:130-36
6. Ramon y Cajal S. Degeneration and regeneration of the nervous system. (Translated May RM) London: Oxford University Press, 1928:92-98
7. Liu HM. Schwann cell properties II. The identity of phagocytes in the degenerating nerve. Am J Pathol 1974;75:395-416
8. Beuche W, Friede RL. The role of non-resident cells in Wallerian Degeneration. J Neurocytol 1984;13:767-96
9. Bigbee JW, Yoshino JE, DeVries GH. Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol 1987;16:487-96
10. Crang AJ, Blakemore WF. Observations on Wallerian degeneration in explant cultures of cat sciatic nerve. J Neurocytol 1986;15:471-82
11. Goodrum JF, Novicki DL. Macrophage-like cells from explant cultures of rat sciatic nerve produce apolipoprotein E. J Neurosci Res 1988;20:457-62
12. Hann Bonnekoh PG, Scheidt P, Friede RL. Myelin phagocytosis by peritoneal macrophages in organ cultures of mouse peripheral nerve. A new model for studying myelin phagocytosis in vitro. J Neuropath Exp Neurol 1989;48:140-53
13. Reichert E, Saada A, Rotshenker S. Peripheral nerve injury induced Schwann cells to express two macrophage phenotypes: Phagocytosis and the galactose-specific lectin MAC-2. J Neurosci 1994;4:3231-45
14. Fernandez-Valle C, Bunge RP, Bunge MB. Schwann cells degrade and proliferate in the absence of macrophages: Evidence from in vitro studies of Wallerian degeneration. J Neurocytol 1995;24:667-79
15. Stoll G, Griffin JW, Li CY, Trapp BD. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989;18:671-83
16. Liu HM, Yang LH, Yang YJ. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropath Exp Neurol 1995;54:487-96
17. Brück W, Friede RL. L-Fucosidase treatment blocks myelin phagocytosis by macrophages in vitro. J Neuroimminol 1990;27:217-27
18. Beuche W, Friede RL. Myelin phagocytosis in Wallerian degeneration of peripheral nerves depends on silica-sensitive, bg/bg-negative and Fc-positive monocytes. Brain Res 1986;378:97-106
19. Müller HW, Minwegan P. Nonresident macrophages in peripheral nerve of rat: Effect of silica on migration, myelin phagocytosis, and apolipoprotein E expression during Wallerian degeneration. J Neurosci Res 1987;18:222-29
20. Tanaka K, Zhang Q-L, Webster HDeF. Myelinated fiber regeneration after sciatic nerve crush: Morphometric observations in young adult and aging mice and the effects of macrophage suppression and conditioning lesions. Exp Neurol 1992;118:53-61
21. Perry VH, Tsao JW, Fearn S, Brown MC. Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice. Eur J Neurosci 1995;7:271-80
22. White FV, Toews AD, Goodrum JF, Novicki DL, Bouldin TW, Morell P. Lipid metabolism during early stages of Wallerian degeneration in the rat sciatic nerve. J Neurochem 1989;52:1085-92
23. Goodrum JF. Cholesterol synthesis is down-regulated during regeneration of peripheral nerve. J Neurochem 1990;54:1709-15
24. Webster GR. Phospholipase A activities in normal and sectioned rat sciatic nerve. J Neurochem 1993;21:873-76
25. Johnson AC, McNabb AR, Rossiter RJ. Chemical studies of peripheral nerve during Wallerian degeneration. I. Lipids. Biochem J 1949;45:500-508
26. Mannell WA. Wallerian degeneration in the rat. A chemical study. Can J Med Sci 1952;30:173-79
27. Wood JG, Dawson RMC. Lipid and protein changes in sciatic nerve during Wallerian degeneration. J Neurochem 1974;22:631-35
28. McDermott JR, Wisniewski HM. Studies on the myelin protein changes and antigenic properties or rabbit sciatic nerves undergoing Wallerian degeneration. J Neurol Sci 1977;33:81-94
29. Goodrum JF, Earnhardt T, Goines N, Bouldin TW. Fate of myelin lipids during degeneration and regeneration of peripheral nerve: An autoradiographic study. J Neurosci 1994;14:357-367
30. Goodrum JF, Weaver JE, Goines ND, Bouldin TW. Fatty acids from degenerating myelin lipids are conserved and reutilized for myelin synthesis during regeneration in peripheral nerve. J Neurochem 1995;65:1752-59
31. 3H in the regeneration of peripheral nerve. Lab Invest 1970;22:237-40
32. 3H in degenerating and regenerating mouse sciatic nerve. J Cell Biol 1972;52:615-25
33. Goodrum JF. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 1991;56:2082-86
34. Skene JHP, Shooter EM. Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci USA 1993;80:4169-73
35. Ignatius MJ, Gebicke-Haerter PJ, Skene JHP, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 1986;83:1125-29
36. Snipes GJ, McGuire CB, Norden JJ, Freeman JA. Nerve injury stimulates the secretion of apolipoprotein E by non-neuronal cells. Proc Natl Acad Sci USA 1986;83:1130-34
37. Gelman BB, Rifia N, Goodrum JF, Bouldin TW, Krigman MR. Apolipoprotein E is released by rat sciatic nerve during segmental demyelination and remyelination. J Neuropath Exp Neurol 1987;46:644-52
38. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30
39. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31
40. Bouldin TW, Goodrum JF. Toxicant-induced demyelinating neuropathy. In: Chang LW, Ed, Principles of neurotoxicology. New York: Marcel Dekker Inc, 1994:211-36
41. Gelman BB, Goodrum JF, Bouldin TW. Macrophage apolipoprotein synthesis and endoneurial distribution as a response to segmental demyelination. J Neuropath Exp Neurol 1991;50:383-407
42. Goodrum JF, Bouldin TW, Zhang SH, Maeda N, Popko B. Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. J Neurochem 1995;64:408-16
43. Scanu AM, Cabana V, Spector AA. Lipoprotein disorders: Defects of apolipoproteins, enzymes, and receptors. In: Scanu AM, Spector AA, eds. Biochemistry and biology of plasma lipoproteins. New York: Marcel Dekker, 1986:453-74
44. Yao JK, Herbert PN. Lipoprotein deficiency and neuromuscular manifestations. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy, third edition. Philadelphia: W.B. Saunders Co, 1993:1179-93
45. Pentchev PG, Brady RO, Blanchette-Mackie EJ, et al. The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochim Biophys Acta 1994;1225:235-43
46. Pentchev PG, Vanier MT, Suzuki K, Patterson MC. Niemann-Pick disease type C: A cellular cholesterol lipidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic and molecular bases of inherited disease. New York: McGraw Hill Inc, 1995:2625-40
47. Hahn AF, Gilbert JJ, Kwarciak C, et al. Nerve biopsy findings in Niemann-Pick type II (NPC). Acta Neuropathol 1994;87:149-54